Rtw Biotech Opportunities annual total assets
2021
2022
2023
2024
2025
Rtw Biotech Opportunities Total Assets Growth & History (RTW)
Rtw Biotech Opportunities's total assets was $1.07B for fiscal 2025.
View full Rtw Biotech Opportunities company overviewRtw Biotech Opportunities annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.07B | $309.0M | +40.66% |
| 2024 | 2024-12-31 | $760.0M | $313.8M | +70.32% |
| 2023 | 2023-12-31 | $446.2M | $44.7M | +11.13% |
| 2022 | 2022-12-31 | $401.5M | −$37.8M | −8.61% |
| 2021 | 2021-12-31 | $439.4M | — | — |
Rtw Biotech Opportunities quarterly total assets
Q4.24
Q2.25
Q4.25
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $1.07B | $309.0M | +40.66% |
| Q2 2025 | 2025-06-30 | $766.1M | — | — |
| Q4 2024 | 2024-12-31 | $760.0M | — | — |
Rtw Biotech Opportunities total assets trends
Between the periods ended 2021-12-31 and 2025-12-31, Rtw Biotech Opportunities's total assets increased from $439.4M to $1.07B, a change of $629.7M. The latest reported quarter, Q4 2025, shows $1.07B.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
reported total assets
TickerStat uses total assets reported in company official filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Rtw Biotech Opportunities source filings ↗